# Axsome Therapeutics, Inc. (AXSM): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Axsome Therapeutics, Inc. (AXSM) is 13/100, ranked against 24,000+ stocks in 35 markets (Quality 34, Value 21, Momentum 33, each scored against its sector).

- StockRank: 13/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 34, Value 21, Momentum 33: each a 0-100 percentile within Healthcare.
- Position: #23,140 overall, #2,175 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 144.06 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 50.0M.

Source: https://moatmap.ai/stock/AXSM
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker